2262. Evaluation of Ceftriaxone Versus Cefazolin as a Surrogate Marker for Cefpodoxime Susceptibility in Enterobacterales Isolates

BACKGROUND: Cefpodoxime is increasingly being explored as an option for intravenous-to-oral step-down therapy in Enterobacterales infections, but it is rarely included in routine susceptibility testing. The Clinical and Laboratory Standards Institute (CLSI) states that cefpodoxime susceptibility amo...

Descripción completa

Detalles Bibliográficos
Autores principales: Lambert, Kaitlyn, Demkowicz, Ryan, Slain, Douglas, Murray, Amanda, Howard, Catessa A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678582/
http://dx.doi.org/10.1093/ofid/ofad500.1884

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678582/
http://dx.doi.org/10.1093/ofid/ofad500.1884

Ejemplares similares